More on DYAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.8 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DYAX Income Statement

Click line-items for a historical chart and %
Product sales, net 17.81M
Development and license fee revenues
Total revenues, net 24.73M
Cost of product sales 784K
Research and development expenses 15.62M
Selling, general and administrative expenses 14.03M
Total costs and expenses 33.22M
Income (loss) from operations -8.49M
Interest income
Interest and other expenses -3.43M
Total other expense -3.21M
Net loss -11.7M
Unrealized gain on investments 58K
Comprehensive loss -11.64M
Basic and diluted net loss per share -0.08
Shares used in computing basic and diluted net loss per share